BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

185 related articles for article (PubMed ID: 6365657)

  • 1. The effects of an alpha-glucoside hydrolase inhibitor on glycemia and the absorption of sucrose in man determined using a tracer method.
    Radziuk J; Kemmer F; Morishima T; Berchtold P; Vranic M
    Diabetes; 1984 Mar; 33(3):207-13. PubMed ID: 6365657
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Scope and specificity of acarbose in slowing carbohydrate absorption in man.
    Jenkins DJ; Taylor RH; Goff DV; Fielden H; Misiewicz JJ; Sarson DL; Bloom SR; Alberti KG
    Diabetes; 1981 Nov; 30(11):951-4. PubMed ID: 7028548
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Inhibition of disaccharide digestion in rat intestine by the alpha-glucosidase inhibitor acarbose (BAY g 5421).
    Krause HP; Keup U; Puls W
    Digestion; 1982; 23(4):232-8. PubMed ID: 6754513
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Response of serum levels of gastric inhibitory polypeptide and insulin to sucrose ingestion during long-term application of acarbose.
    Fölsch UR; Ebert R; Creutzfeldt W
    Scand J Gastroenterol; 1981; 16(5):629-32. PubMed ID: 7034156
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Optimum effectiveness of intestinal alpha-glucosidase inhibitors: importance of uniform distribution through a meal.
    O'Dea K; Turton J
    Am J Clin Nutr; 1985 Mar; 41(3):511-6. PubMed ID: 3883743
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Delayed gastric emptying occurs following acarbose administration and is a further mechanism for its anti-hyperglycaemic effect.
    Ranganath L; Norris F; Morgan L; Wright J; Marks V
    Diabet Med; 1998 Feb; 15(2):120-4. PubMed ID: 9507911
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Effect of alpha-glucosidehydrolase inhibition and intestinal absorption of sucrose, water, and sodium in man.
    Caspary WF; Kalisch H
    Gut; 1979 Sep; 20(9):750-5. PubMed ID: 387540
    [TBL] [Abstract][Full Text] [Related]  

  • 8. alpha-Glucosidase inhibition in obesity.
    William-Olsson T
    Acta Med Scand Suppl; 1985; 706():1-39. PubMed ID: 3914827
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Enteroglucagon release in disaccharide malabsorption induced by intestinal alpha-glucosidase inhibition.
    Hayakawa T; Kondo T; Okumura N; Nagai K; Shibata T; Kitagawa M
    Am J Gastroenterol; 1989 May; 84(5):523-6. PubMed ID: 2655436
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Combined use of guar and acarbose in reduction of postprandial glycaemia.
    Jenkins DJ; Taylor RH; Nineham R; Goff DV; Bloom SR; Sarson D; Alberti KG
    Lancet; 1979 Nov; 2(8149):924-7. PubMed ID: 91023
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Effects of the disaccharidase inhibitor acarbose on meal and intravenous glucose tolerance in normal man.
    Dimitriadis G; Tessari P; Go V; Gerich J
    Metabolism; 1982 Aug; 31(8):841-3. PubMed ID: 7047984
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Prolonged and enhanced secretion of glucagon-like peptide 1 (7-36 amide) after oral sucrose due to alpha-glucosidase inhibition (acarbose) in Type 2 diabetic patients.
    Seifarth C; Bergmann J; Holst JJ; Ritzel R; Schmiegel W; Nauck MA
    Diabet Med; 1998 Jun; 15(6):485-91. PubMed ID: 9632123
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Effects of graded alpha-glucosidase inhibition on sugar absorption in vivo.
    Madariaga H; Lee PC; Heitlinger LA; Lebenthal E
    Dig Dis Sci; 1988 Aug; 33(8):1020-4. PubMed ID: 3292164
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Glucagon-like peptide 1 (7-36 amide) secretion in response to luminal sucrose from the upper and lower gut. A study using alpha-glucosidase inhibition (acarbose).
    Qualmann C; Nauck MA; Holst JJ; Orskov C; Creutzfeldt W
    Scand J Gastroenterol; 1995 Sep; 30(9):892-6. PubMed ID: 8578189
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Adaptation of the small intestine to induced maldigestion in rats. Experimental pancreatic atrophy and acarbose feeding.
    Creutzfeldt W; Fölsch UR; Elsenhans B; Ballmann M; Conlon JM
    Scand J Gastroenterol Suppl; 1985; 112():45-53. PubMed ID: 3892654
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Utilization of oral sucrose load during exercise in humans. Effect of the alpha-glucosidase inhibitor acarbose.
    Gerard J; Jandrain B; Pirnay F; Pallikarakis N; Krzentowski G; Lacroix M; Mosora F; Luyckx AS; Lefèbvre PJ
    Diabetes; 1986 Nov; 35(11):1294-301. PubMed ID: 3530858
    [TBL] [Abstract][Full Text] [Related]  

  • 17. alpha-Glucosidase inhibition improves postprandial hyperglycemia and decreases insulin requirements in insulin-dependent diabetes mellitus.
    Dimitriadis GD; Tessari P; Go VL; Gerich JE
    Metabolism; 1985 Mar; 34(3):261-5. PubMed ID: 3883097
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Acute and short term effects of intestinal alpha-glucosidase inhibition on gut hormone responses in man.
    Uttenthal LO; Ukponmwan OO; Ghiglione M; Bloom SR
    Dig Dis Sci; 1987 Feb; 32(2):139-44. PubMed ID: 3542445
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Influence of metronidazole on the breath hydrogen response and symptoms in acarbose-induced malabsorption of sucrose.
    Lembcke B; Fölsch UR; Caspary WF; Ebert R; Creutzfeldt W
    Digestion; 1982; 25(3):186-93. PubMed ID: 7160549
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Sucrose malabsorption in man after ingestion of alpha-glucosidehydrolase inhibitor.
    Caspary WF
    Lancet; 1978 Jun; 1(8076):1231-3. PubMed ID: 77996
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.